Literature DB >> 22696661

Impact of VP1-specific protein sequence motifs on adeno-associated virus type 2 intracellular trafficking and nuclear entry.

Ruth Popa-Wagner1, Manvi Porwal, Michael Kann, Matthias Reuss, Marc Weimer, Luise Florin, Jürgen A Kleinschmidt.   

Abstract

Adeno-associated virus type 2 (AAV2) has gained much interest as a gene delivery vector. A hallmark of AAV2-mediated gene transfer is an intracellular conformational change of the virus capsid, leading to the exposure of infection-relevant protein domains. These protein domains, which are located on the N-terminal portion of the structural proteins VP1 and VP2, include a catalytic phospholipase A(2) domain and three clusters of basic amino acids. We have identified additional protein sequence motifs located on the VP1/2 N terminus that also proved to be obligatory for virus infectivity. These motifs include signals that are known to be involved in protein interaction, endosomal sorting and signal transduction in eukaryotic cells. Among different AAV serotypes they are highly conserved and mutation of critical amino acids of the respective motifs led to a severe infection-deficient phenotype. In particular, mutation of a YXXQ-sequence motif significantly reduced accumulation of virus capsids around the nucleus in comparison to wild-type AAV2. Interestingly, intracellular trafficking of AAV2 was shown to be independent of PLA(2) activity. Moreover, mutation of three PDZ-binding motifs, which are located consecutively at the very tip of the VP1 N terminus, revealed a nuclear transport-defective phenotype, suggesting a role in nuclear uptake of the virus through an as-yet-unknown mechanism.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22696661      PMCID: PMC3416132          DOI: 10.1128/JVI.00282-12

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  63 in total

1.  Impaired intracellular trafficking of adeno-associated virus type 2 vectors limits efficient transduction of murine fibroblasts.

Authors:  J Hansen; K Qing; H J Kwon; C Mah; A Srivastava
Journal:  J Virol       Date:  2000-01       Impact factor: 5.103

2.  A conformational change in the adeno-associated virus type 2 capsid leads to the exposure of hidden VP1 N termini.

Authors:  Stephanie Kronenberg; Bettina Böttcher; Claus W von der Lieth; Svenja Bleker; Jürgen A Kleinschmidt
Journal:  J Virol       Date:  2005-05       Impact factor: 5.103

Review 3.  Adeno-associated virus vectors: potential applications for cancer gene therapy.

Authors:  Chengwen Li; Dawn E Bowles; Terry van Dyke; Richard Jude Samulski
Journal:  Cancer Gene Ther       Date:  2005-12       Impact factor: 5.987

4.  Infectious entry pathway of adeno-associated virus and adeno-associated virus vectors.

Authors:  J S Bartlett; R Wilcher; R J Samulski
Journal:  J Virol       Date:  2000-03       Impact factor: 5.103

5.  Green fluorescent protein-tagged adeno-associated virus particles allow the study of cytosolic and nuclear trafficking.

Authors:  Kerstin Lux; Nico Goerlitz; Stefanie Schlemminger; Luca Perabo; Daniela Goldnau; Jan Endell; Kristin Leike; David M Kofler; Stefan Finke; Michael Hallek; Hildegard Büning
Journal:  J Virol       Date:  2005-09       Impact factor: 5.103

6.  Dynamin is required for recombinant adeno-associated virus type 2 infection.

Authors:  D Duan; Q Li; A W Kao; Y Yue; J E Pessin; J F Engelhardt
Journal:  J Virol       Date:  1999-12       Impact factor: 5.103

7.  Mutational analysis of the adeno-associated virus type 2 (AAV2) capsid gene and construction of AAV2 vectors with altered tropism.

Authors:  P Wu; W Xiao; T Conlon; J Hughes; M Agbandje-McKenna; T Ferkol; T Flotte; N Muzyczka
Journal:  J Virol       Date:  2000-09       Impact factor: 5.103

8.  Endocytosis and nuclear trafficking of adeno-associated virus type 2 are controlled by rac1 and phosphatidylinositol-3 kinase activation.

Authors:  S Sanlioglu; P K Benson; J Yang; E M Atkinson; T Reynolds; J F Engelhardt
Journal:  J Virol       Date:  2000-10       Impact factor: 5.103

9.  Endosomal processing limits gene transfer to polarized airway epithelia by adeno-associated virus.

Authors:  D Duan; Y Yue; Z Yan; J Yang; J F Engelhardt
Journal:  J Clin Invest       Date:  2000-06       Impact factor: 14.808

10.  Protein production by auto-induction in high density shaking cultures.

Authors:  F William Studier
Journal:  Protein Expr Purif       Date:  2005-05       Impact factor: 1.650

View more
  31 in total

Review 1.  Adeno-associated Virus as a Mammalian DNA Vector.

Authors:  Max Salganik; Matthew L Hirsch; Richard Jude Samulski
Journal:  Microbiol Spectr       Date:  2015-08

2.  OneBac 2.0: Sf9 Cell Lines for Production of AAV5 Vectors with Enhanced Infectivity and Minimal Encapsidation of Foreign DNA.

Authors:  Mario Mietzsch; Vincent Casteleyn; Stefan Weger; Sergei Zolotukhin; Regine Heilbronn
Journal:  Hum Gene Ther       Date:  2015-08-06       Impact factor: 5.695

3.  SUMOylation Targets Adeno-associated Virus Capsids but Mainly Restricts Transduction by Cellular Mechanisms.

Authors:  Qingxin Chen; Robin Njenga; Barbara Leuchs; Susanna Chiocca; Jürgen Kleinschmidt; Martin Müller
Journal:  J Virol       Date:  2020-09-15       Impact factor: 5.103

4.  Recombinant adeno-associated virus utilizes host cell nuclear import machinery to enter the nucleus.

Authors:  Sarah C Nicolson; R Jude Samulski
Journal:  J Virol       Date:  2014-01-29       Impact factor: 5.103

5.  High-Density Recombinant Adeno-Associated Viral Particles are Competent Vectors for In Vivo Transduction.

Authors:  Qizhao Wang; Jenni Firrman; Zhongren Wu; Katie A Pokiniewski; C Alexander Valencia; Hairong Wang; Hongying Wei; Zhenjing Zhuang; LinShu Liu; Stephanie L Wunder; Mario P S Chin; Ruian Xu; Yong Diao; Biao Dong; Weidong Xiao
Journal:  Hum Gene Ther       Date:  2016-08-22       Impact factor: 5.695

6.  Cytoplasmic Parvovirus Capsids Recruit Importin Beta for Nuclear Delivery.

Authors:  Elina Mäntylä; Vesa Aho; Michael Kann; Maija Vihinen-Ranta
Journal:  J Virol       Date:  2020-01-31       Impact factor: 5.103

Review 7.  Adeno-Associated Virus Vectors and Stem Cells: Friends or Foes?

Authors:  Nolan Brown; Liujiang Song; Nageswara R Kollu; Matthew L Hirsch
Journal:  Hum Gene Ther       Date:  2017-06       Impact factor: 5.695

8.  Gene transfer properties and structural modeling of human stem cell-derived AAV.

Authors:  Laura J Smith; Taihra Ul-Hasan; Sarah K Carvaines; Kim Van Vliet; Ethel Yang; Kamehameha K Wong; Mavis Agbandje-McKenna; Saswati Chatterjee
Journal:  Mol Ther       Date:  2014-06-13       Impact factor: 11.454

9.  Structure and dynamics of adeno-associated virus serotype 1 VP1-unique N-terminal domain and its role in capsid trafficking.

Authors:  Balasubramanian Venkatakrishnan; Joseph Yarbrough; John Domsic; Antonette Bennett; Brian Bothner; Olga G Kozyreva; R Jude Samulski; Nicholas Muzyczka; Robert McKenna; Mavis Agbandje-McKenna
Journal:  J Virol       Date:  2013-02-20       Impact factor: 5.103

10.  Adeno-associated virus capsid proteins may play a role in transcription and second-strand synthesis of recombinant genomes.

Authors:  Maxim Salganik; Fikret Aydemir; Hyun-Joo Nam; Robert McKenna; Mavis Agbandje-McKenna; Nicholas Muzyczka
Journal:  J Virol       Date:  2013-11-06       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.